Literature DB >> 28740673

Clinical and pathological aspects of microscopic thymoma with myasthenia gravis and review of published reports.

Mitsuro Fukuhara1, Mitsunori Higuchi1, Yuki Owada1, Takuya Inoue1, Yuzuru Watanabe1, Takumi Yamaura1, Satoshi Muto1, Takeo Hasegawa1, Hiroyuki Suzuki1.   

Abstract

BACKGROUND: Microscopic thymomas, defined as epithelial proliferations smaller than 1 mm in diameter, characteristically occur in patients with myasthenia gravis without macroscopic thymic epithelial tumors. However, some clinical and pathological aspects of this entity are still unclear.
METHODS: This retrospective study includes five consecutive patients who had undergone extended thymectomy for myasthenia gravis at our institution from April 2007 to March 2016 and in whom microscopic thymomas were diagnosed by histopathological examination of the resected specimens. During the same period, we performed 32 extended transsternal thymothymectomies/thymectomies in patients with myasthenia gravis, including the above five cases. We here review 18 cases of microscopic thymoma, including our five cases and 13 previously reported cases.
RESULTS: The incidence of previously undiagnosed microscopic thymoma in patients undergoing thymectomy for myasthenia gravis in our institution is 15.2%. Serum preoperative anti-acetylcholine receptor antibody (anti-AchR Ab) titers were abnormally high in all of our five cases h (74.4±53.3 nmol/L) and decreased significantly after surgery (11.7±13.5 nmol/L, P=0.037). We divided our cases into the following three groups: microscopic thymoma group (Group M), thymoma group (Group T) and non-thymic tumor group (Group N). The mean preoperative anti-AchR Ab titers of these groups were 74.4, 26.5, and 368 nmol/L, respectively. All these values decreased postoperatively. The mean anti-AchR Ab titer was significantly higher in Group M than in Group T (P=0.034). All five cases in Group M were found by post-operative pathological examination to have multifocal type A thymomas.
CONCLUSIONS: Microscopic thymomas tend to be multifocal type A thymomas. Anti-AchR Ab titers decreased significantly in all groups. It is very important to both perform complete extended thymectomies in patients with myasthenia gravis and pathological examination of thin slices of thymic tissue to maximize detection of microscopic thymomas.

Entities:  

Keywords:  Microscopic thymoma; anti-acetylcholine receptor antibody (Anti-AchR Ab); myasthenia gravis

Year:  2017        PMID: 28740673      PMCID: PMC5506161          DOI: 10.21037/jtd.2017.05.22

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  17 in total

Review 1.  Microscopic thymoma: a report of four cases with review of literature.

Authors:  Pradeep Vaideeswar
Journal:  Indian J Pathol Microbiol       Date:  2011 Jul-Sep       Impact factor: 0.740

2.  Microthymoma: definition of the entity and distinction from nodular hyperplasia of the thymic epithelium (so-called microscopic thymoma).

Authors:  Wah Cheuk; William Y W Tsang; John K C Chan
Journal:  Am J Surg Pathol       Date:  2005-03       Impact factor: 6.394

3.  [Microscopic thymoma and myasthenia gravis].

Authors:  G Poulard; J F Mosnier; J M Dumollard; J M Prades; P Convers; S Boucheron
Journal:  Ann Pathol       Date:  1994       Impact factor: 0.407

4.  Microscopic-sized "microthymoma" in patients with myasthenia gravis.

Authors:  Takeshi Mori; Hiroaki Nomori; Koei Ikeda; Hironori Kobayashi; Kazunori Iwatani; Masakazu Yoshioka; Ken-Ichi Iyama
Journal:  Chest       Date:  2007-03       Impact factor: 9.410

5.  Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies.

Authors:  Eric A Engels; Ruth M Pfeiffer
Journal:  Int J Cancer       Date:  2003-07-01       Impact factor: 7.396

6.  Active ectopic thymus predicts poor outcome after thymectomy in class III myasthenia gravis.

Authors:  Vincenzo Ambrogi; Tommaso Claudio Mineo
Journal:  J Thorac Cardiovasc Surg       Date:  2011-12-17       Impact factor: 5.209

7.  The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer.

Authors:  Meinoshin Okumura; Mitsunori Ohta; Yukiyasu Takeuchi; Hiroyuki Shiono; Masayoshi Inoue; Kenjiro Fukuhara; Yoshihisa Kadota; Shinichiro Miyoshi; Yoshitaka Fujii; Hikaru Matsuda
Journal:  J Thorac Cardiovasc Surg       Date:  2003-12       Impact factor: 5.209

8.  A nodular hyperplasia of the thymic epithelium (so-called microscopic thymoma).

Authors:  R Cornea; Elena Lazăr; Alis Dema; Diana Herman
Journal:  Rom J Morphol Embryol       Date:  2009       Impact factor: 1.033

Review 9.  Clinical and pathological aspects of thymic epithelial tumors.

Authors:  Meinoshin Okumura; Hiroyuki Shiono; Masato Minami; Masayoshi Inoue; Tomoki Utsumi; Yoshihisa Kadota; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-01-22

10.  Microscopic thymoma and myasthenia gravis.

Authors:  F Puglisi; N Finato; L Mariuzzi; C Marchini; G Floretti; C A Beltrami
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

View more
  3 in total

Review 1.  Signs heralding appearance of thymomas after extended thymectomy for myasthenia gravis.

Authors:  Ernestina Santos; Ana Martins Silva; Philipp Stroebel; Antonio Marinho; Nick Willcox; Guilherme Goncalves; Carlos Lopes; Alexander Marx; Maria Isabel Leite
Journal:  Neurol Clin Pract       Date:  2019-02

2.  Inflammatory myopathy with myasthenia gravis: Thymoma association and polymyositis pathology.

Authors:  Naohiro Uchio; Kenichiro Taira; Chiseko Ikenaga; Masato Kadoya; Atsushi Unuma; Kenji Yoshida; Setsu Nakatani-Enomoto; Yuki Hatanaka; Yasuhisa Sakurai; Yasushi Shiio; Kenichi Kaida; Akatsuki Kubota; Tatsushi Toda; Jun Shimizu
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-12-24

3.  Primary mediastinal neoplasms: a report of 1,005 cases from a single institution.

Authors:  Malgorzata Szolkowska; Ewa Szczepulska-Wojcik; Beata Maksymiuk; Barbara Burakowska; Sebastian Winiarski; Juliusz Gatarek; Piotr Rudzinski; Tadeusz Orlowski; Renata Langfort
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.